£149.31

Springer Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2

Price data last checked 34 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£149 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 57 days • 57 data points (No recent data available)

Historical
Generating forecast...
£149.64 £149.28 £149.36 £149.44 £149.51 £149.59 £149.67 05 April 2026 19 April 2026 03 May 2026 17 May 2026 31 May 2026

Price Distribution

Price distribution over 57 days • 1 price levels

Days at Price
57 days 0 14 29 43 57 £149 Days at Price

Price Analysis

Most common price: £149 (57 days, 100.0%)

Price range: £149 - £149

Price levels: 1 different prices over 57 days

Description

The 7th International Symposium on Platinum and other metal coordination compounds in Cancer Chemotherapy, ISPCC '95, organized by the European Cancer Centre, was held in Amsterdam, the Netherlands, March 1-4, 1995. As with previous ISPCC meetings, the goal of ISPCC '95 was to bring together c1inicians, clinical investigators, scientists, and laboratory workers from many disciplines to promote further collaboration and cooperation in the development of new platinum and other metal coordination compounds as weil as in new ways to use 'c1assical' drugs as cisplatin and carboplatin in the treatment of cancer. Important aspects addressed by experts in the field inc1uded the synthesis and activity of new platinum compounds, the biochemistry and molecular pharrnacology as weil as the c1inical pharrnacology of this c1ass of antineoplastic agents, an overview of current c1inical studies, one special minisymposium on the mechanisms of cell kill of platinum, and one on resistance against platinum compounds. Finally, the current status of development of nonplatinum metal complexes was discussed. This volume contains the contributions of the various speakers at ISPCC '95 and provides an up-to-date and comprehensive overview of this important c1ass of anticancer agents, ranging from synthesis and molecular pharrnacology on one hand to c1inical pharrnacology and cIinical investigations on the other hand. The Organizing Corrunittee and Editors wish to express their gratitude to the contributors to this volume, to the various organizations and pharrnaceutical companies for their generous sponsoring of ISPCC '95, and to the Plenum Publishing Company for their help in producing this volume.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
20 June 2013
Listed Since
07 November 2013

Barcode

No barcode data available

Similar Products You Might Like

Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications (Cancer Drug Discovery and Development)
83% match

Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications (Cancer Drug Discovery and Development)

Humana

£144.22 18 May 2026
Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy: 10 (Progress in Clinical Biochemistry and Medicine, 10)
83% match

Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy: 10 (Progress in Clinical Biochemistry and Medicine, 10)

Springer

£109.06 03 Jun 2026
Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II): Thiol “Switch-on” Fluorescent Probes, Thioredoxin Reductase ... Reticulum Targeting Agents (Springer Theses)
81% match

Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II): Thiol “Switch-on” Fluorescent Probes, Thioredoxin Reductase ... Reticulum Targeting Agents (Springer Theses)

Springer

£74.27 02 Jun 2026
Cisplatin: Pharmacology, Clinical Uses & Adverse Effects (Pharmacology - Research, Safety Testing and Regulation: Cancer Etiology, Diagnosis and Treatments)
81% match

Cisplatin: Pharmacology, Clinical Uses & Adverse Effects (Pharmacology - Research, Safety Testing and Regulation: Cancer Etiology, Diagnosis and Treatments)

£77.87 15 Jun 2026
New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)
81% match

New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)

Springer

£77.83 31 May 2026
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
80% match

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Springer

£107.85 31 May 2026
Cancer II: 28 (Topics in Medicinal Chemistry, 28)
79% match

Cancer II: 28 (Topics in Medicinal Chemistry, 28)

Springer

£199.19 20 May 2026
Pharmaceutical Perspectives of Cancer Therapeutics
79% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 06 Jun 2026
Pharmacotherapeutic Botanicals for Cancer Chemoprevention
78% match

Pharmacotherapeutic Botanicals for Cancer Chemoprevention

Springer

£100.08 30 May 2026
Molecular Targeted Therapy of Lung Cancer
78% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.70 06 Jun 2026
Anticarcinogenesis and Radiation Protection 2
78% match

Anticarcinogenesis and Radiation Protection 2

Springer

£123.37 24 May 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
78% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 05 Jun 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
78% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£163.85 31 May 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
78% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£74.87 24 May 2026
Cell Signaling & Molecular Targets in Cancer
78% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 14 May 2026
New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)
78% match

New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)

Springer

£129.15 24 Jun 2026
The Privileged Pincer-Metal Platform: Coordination Chemistry & Applications: 54 (Topics in Organometallic Chemistry)
78% match

The Privileged Pincer-Metal Platform: Coordination Chemistry & Applications: 54 (Topics in Organometallic Chemistry)

Springer

£179.99 28 May 2026
Regulation of Carcinogenesis, Angiogenesis and Metastasis by the Proprotein Convertases (PC's): A New Potential Strategy in Cancer Therapy
78% match

Regulation of Carcinogenesis, Angiogenesis and Metastasis by the Proprotein Convertases (PC's): A New Potential Strategy in Cancer Therapy

Springer

£113.76 09 Jun 2026
Cancer Drug Discovery: Science and History
78% match

Cancer Drug Discovery: Science and History

Springer

£109.19 24 May 2026
Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)
77% match

Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)

Springer

£74.57 02 Jun 2026
Higher Oxidation State Organopalladium and Platinum Chemistry: 35 (Topics in Organometallic Chemistry, 35)
77% match

Higher Oxidation State Organopalladium and Platinum Chemistry: 35 (Topics in Organometallic Chemistry, 35)

Springer

£107.98 06 Jun 2026
Food Factors for Cancer Prevention
77% match

Food Factors for Cancer Prevention

Springer

£78.84 18 May 2026
Risk Assessment in Chemical Carcinogenesis: 1991 / 1991/1 (Sitzungsberichte der Heidelberger Akademie der Wissenschaften, 1991 / 1991/1)
77% match

Risk Assessment in Chemical Carcinogenesis: 1991 / 1991/1 (Sitzungsberichte der Heidelberger Akademie der Wissenschaften, 1991 / 1991/1)

Springer

£89.43 05 Jun 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
77% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 25 May 2026